k562 luc2 tumor cells Search Results


tumor cell k 562 lucena mdr atcc ccl 243 luc2 tm  (ATCC)
94
ATCC tumor cell k 562 lucena mdr atcc ccl 243 luc2 tm
Tumor Cell K 562 Lucena Mdr Atcc Ccl 243 Luc2 Tm, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/k562+luc2+tumor+cells/K-562-luc2/pm34463267-128-0-5
Average 94 stars, based on 1 article reviews
tumor cell k 562 lucena mdr atcc ccl 243 luc2 tm - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
220 k562 luc2 tumor cells  (ATCC)
99
ATCC 220 k562 luc2 tumor cells
220 K562 Luc2 Tumor Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/k562+luc2+tumor+cells/K-562/10__1158_slash_2767___9764__crc___23___0570-85-31-35
Average 99 stars, based on 1 article reviews
220 k562 luc2 tumor cells - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
k562-luc2  (BIOCYTOGEN ltd)
90
BIOCYTOGEN ltd k562-luc2
A. t-SNE projections of primary human islet cells. B. t-SNE projections of GAPDH expression across the assigned populations. Cells are colored according to their assigned cluster. (Adapted from Segerstolpe et al., 2016) C. Schematic of homology directed repair plasmids for integration of <t>Luc2</t> and PD-L1 at the GAPDH locus. D. Schematic GAPDH-targeting Luc2 and peptide::B2M::HLA-E HDR plasmid. E. Schematic of the peptide::B2M::HLA-E long-chain fusion. F. PD1-Fc binding assay. PD-L1 and WT SC-islet cells were dissociated and stained with a 2-fold dilution series of PE-conjugated human and mouse PD1-Fc. Data is presented as MFI normalized to mode. G. FACS sorting strategy of HLA-ABC -/- hESCs. H. FACS gating strategy for quantification of Nkx6.1 + /C-pep + SC-β cells following in vitro differentiation.
K562 Luc2, supplied by BIOCYTOGEN ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/k562+luc2+tumor+cells/k562+luc2/bio_rxiv__2022__05__09__487072-164-0-1
Average 90 stars, based on 1 article reviews
k562-luc2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
k562-luc2 bioware  (BioWare Corporation)
90
BioWare Corporation k562-luc2 bioware
A. t-SNE projections of primary human islet cells. B. t-SNE projections of GAPDH expression across the assigned populations. Cells are colored according to their assigned cluster. (Adapted from Segerstolpe et al., 2016) C. Schematic of homology directed repair plasmids for integration of <t>Luc2</t> and PD-L1 at the GAPDH locus. D. Schematic GAPDH-targeting Luc2 and peptide::B2M::HLA-E HDR plasmid. E. Schematic of the peptide::B2M::HLA-E long-chain fusion. F. PD1-Fc binding assay. PD-L1 and WT SC-islet cells were dissociated and stained with a 2-fold dilution series of PE-conjugated human and mouse PD1-Fc. Data is presented as MFI normalized to mode. G. FACS sorting strategy of HLA-ABC -/- hESCs. H. FACS gating strategy for quantification of Nkx6.1 + /C-pep + SC-β cells following in vitro differentiation.
K562 Luc2 Bioware, supplied by BioWare Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/k562+luc2+tumor+cells/k562/pmc04457455-43-15-16
Average 90 stars, based on 1 article reviews
k562-luc2 bioware - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
crl 2408 k562 luc2 biocytogen  (ATCC)
96
ATCC crl 2408 k562 luc2 biocytogen
A. t-SNE projections of primary human islet cells. B. t-SNE projections of GAPDH expression across the assigned populations. Cells are colored according to their assigned cluster. (Adapted from Segerstolpe et al., 2016) C. Schematic of homology directed repair plasmids for integration of <t>Luc2</t> and PD-L1 at the GAPDH locus. D. Schematic GAPDH-targeting Luc2 and peptide::B2M::HLA-E HDR plasmid. E. Schematic of the peptide::B2M::HLA-E long-chain fusion. F. PD1-Fc binding assay. PD-L1 and WT SC-islet cells were dissociated and stained with a 2-fold dilution series of PE-conjugated human and mouse PD1-Fc. Data is presented as MFI normalized to mode. G. FACS sorting strategy of HLA-ABC -/- hESCs. H. FACS gating strategy for quantification of Nkx6.1 + /C-pep + SC-β cells following in vitro differentiation.
Crl 2408 K562 Luc2 Biocytogen, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/k562+luc2+tumor+cells/NK-92+MI/pm36599351-493-38-36
Average 96 stars, based on 1 article reviews
crl 2408 k562 luc2 biocytogen - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

Image Search Results


A. t-SNE projections of primary human islet cells. B. t-SNE projections of GAPDH expression across the assigned populations. Cells are colored according to their assigned cluster. (Adapted from Segerstolpe et al., 2016) C. Schematic of homology directed repair plasmids for integration of Luc2 and PD-L1 at the GAPDH locus. D. Schematic GAPDH-targeting Luc2 and peptide::B2M::HLA-E HDR plasmid. E. Schematic of the peptide::B2M::HLA-E long-chain fusion. F. PD1-Fc binding assay. PD-L1 and WT SC-islet cells were dissociated and stained with a 2-fold dilution series of PE-conjugated human and mouse PD1-Fc. Data is presented as MFI normalized to mode. G. FACS sorting strategy of HLA-ABC -/- hESCs. H. FACS gating strategy for quantification of Nkx6.1 + /C-pep + SC-β cells following in vitro differentiation.

Journal: bioRxiv

Article Title: Secreted cytokines provide local immune tolerance for human stem cell-derived islets

doi: 10.1101/2022.05.09.487072

Figure Lengend Snippet: A. t-SNE projections of primary human islet cells. B. t-SNE projections of GAPDH expression across the assigned populations. Cells are colored according to their assigned cluster. (Adapted from Segerstolpe et al., 2016) C. Schematic of homology directed repair plasmids for integration of Luc2 and PD-L1 at the GAPDH locus. D. Schematic GAPDH-targeting Luc2 and peptide::B2M::HLA-E HDR plasmid. E. Schematic of the peptide::B2M::HLA-E long-chain fusion. F. PD1-Fc binding assay. PD-L1 and WT SC-islet cells were dissociated and stained with a 2-fold dilution series of PE-conjugated human and mouse PD1-Fc. Data is presented as MFI normalized to mode. G. FACS sorting strategy of HLA-ABC -/- hESCs. H. FACS gating strategy for quantification of Nkx6.1 + /C-pep + SC-β cells following in vitro differentiation.

Article Snippet: K562-Luc2 (Biocytogen, BCG-PS-015-luc) and Raji-GFP-Luc2 (Biocytogen, BCG-PS-087-luc) cells were used as positive and negative controls respectively.

Techniques: Expressing, Plasmid Preparation, Binding Assay, Staining, In Vitro

A. Quantification of SC-β cell survival when co-cultured with NK92mi cells. K562 and Raji cells were used as positive and negative controls, respectively. Cell survival is presented as mean ± SD (n = 5). B. NKG2A/NKG2C expression on NK92mi cells. C. FACS gating strategy of CD56 + NK cells enriched from human apheresis leukoreductions. Gates for specific population include all CD56 + NK cells (red), CD56 high (green) and CD56 dim (pink). Plots are representative of 5 donors. D. Quantitative analysis of CD56 expression on enriched primary human NK cells. Data is presented as % CD56 expression ( n = 5). E. In vivo NK cell assay. Bioluminescence imaging was performed on day 1 and 5 post-transplantation. F. Schematic of SC-endothelial cell differentiation protocol. G. FACS analysis of the endothelial cell marker CD31 in SC-endothelial cells derived from WT and B2M -/- hESCs.

Journal: bioRxiv

Article Title: Secreted cytokines provide local immune tolerance for human stem cell-derived islets

doi: 10.1101/2022.05.09.487072

Figure Lengend Snippet: A. Quantification of SC-β cell survival when co-cultured with NK92mi cells. K562 and Raji cells were used as positive and negative controls, respectively. Cell survival is presented as mean ± SD (n = 5). B. NKG2A/NKG2C expression on NK92mi cells. C. FACS gating strategy of CD56 + NK cells enriched from human apheresis leukoreductions. Gates for specific population include all CD56 + NK cells (red), CD56 high (green) and CD56 dim (pink). Plots are representative of 5 donors. D. Quantitative analysis of CD56 expression on enriched primary human NK cells. Data is presented as % CD56 expression ( n = 5). E. In vivo NK cell assay. Bioluminescence imaging was performed on day 1 and 5 post-transplantation. F. Schematic of SC-endothelial cell differentiation protocol. G. FACS analysis of the endothelial cell marker CD31 in SC-endothelial cells derived from WT and B2M -/- hESCs.

Article Snippet: K562-Luc2 (Biocytogen, BCG-PS-015-luc) and Raji-GFP-Luc2 (Biocytogen, BCG-PS-087-luc) cells were used as positive and negative controls respectively.

Techniques: Cell Culture, Expressing, In Vivo, Imaging, Transplantation Assay, Cell Differentiation, Marker, Derivative Assay